SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001479290-19-000067
Filing Date
2019-06-06
Accepted
2019-06-06 19:19:44
Documents
2
Period of Report
2019-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155986316763641.html 3  
1 FORM 3 wf-form3_155986316763641.xml 3 1736
2 BERAUD POA ex-24.htm EX-24 3646
  Complete submission text file 0001479290-19-000067.txt   6725
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LEVI STRAUSS & CO. 1155 BATTERY STREET SAN FRANCISCO CA 94111
Business Address
Beraud Jill (Reporting) CIK: 0001520061 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 19883848